Open access
Open access
Powered by Google Translator Translator

FDA Report: 660 Cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma

11 Feb, 2019 | 00:10h | UTC

Medical Device Reports of Breast Implant-Associated Anaplastic Large Cell Lymphoma – U.S. Food and Drug Administration (FDA) (free)

Commentary: FDA Emphasizes Lymphoma Risk in Women with Breast Implants – NEJM Journal Watch (free)

Related: Study: Long-term Outcomes of Silicone Breast Implants (link to abstract and commentary) AND Research: Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast (link to abstract and commentary) AND Breast Implant-Associated Anaplastic Large Cell Lymphoma (link to previous FDA report and commentaries)